SCHEMBL24377041

SCHEMBL24377041

c1ccc(-c2cccc3c(-c4ccc5cc(-c6nc(-c7ccc8ccccc8c7)nc(-c7ccc8ccccc8c7)n6)ccc5c4)cccc23)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 2/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
TNF P01375 1/20 0.45
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
HDAC4 P56524 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
CYP1A1 P04798 1/20 0.44
CYP1B1 Q16678 1/20 0.44
GPR84 Q9NQS5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798766 0.95 MCL1 (0.46) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL27216702 0.95 GSTP1 (0.46) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL24377040 0.95 GSTP1 (0.48) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25798751 0.94 MCL1 (0.44) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL27216699 0.93 MEN1 (0.47) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL23633501 0.93 ALDH1A1 (0.47) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL27456296 0.93 ALDH1A1 (0.44) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25798675 0.92 ALDH1A1 (0.47) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL25680773 0.92 ALDH1A1 (0.46) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL23633494 0.92 TNF (0.47) GSTP1SMN1; SMN2ALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 GSTP1 2312/4885SMN1; SMN2 695/4885ALDH1A1 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.